DARROWS SOLUTION Ireland - English - HPRA (Health Products Regulatory Authority)

darrows solution

company liquidated m123 - lactic acid sodium hydroxide hydrochloric acid potassium chloride sodium chloride - 1 litre

Sodium Chloride Intravenous Infusion BP 0.9% w/v (viaflex container) Ireland - English - HPRA (Health Products Regulatory Authority)

sodium chloride intravenous infusion bp 0.9% w/v (viaflex container)

baxter holding b.v. - sodium chloride - solution for infusion - 0.9 percent weight/volume - electrolyte solutions; sodium chloride

Potassium Chloride 0.15% w/v & Glucose 5% w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

potassium chloride 0.15% w/v & glucose 5% w/v solution for infusion

fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.15 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes

Potassium Chloride 0.3% w/v & Glucose 5% w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

potassium chloride 0.3% w/v & glucose 5% w/v solution for infusion

fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.3 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes.

VOLULYTE 6% Australia - English - Department of Health (Therapeutic Goods Administration)

volulyte 6%

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; hydroxyethyl starch 130/0.4, quantity: 60 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of volulyte is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

LACTATED RINGERS AND DEXTROSE- sodium lactate, potassium chloride, calcium chloride, sodium chloride, dextrose injection, soluti United States - English - NLM (National Library of Medicine)

lactated ringers and dextrose- sodium lactate, potassium chloride, calcium chloride, sodium chloride, dextrose injection, soluti

hf acquisition co llc, dba healthfirst - sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn486 - these solutions are indicated for parenteral replacement of extracellular losses of fluid and electrolytes, with or without minimal carbohydrate calories, as required by the clinical condition of the patient. solutions containing lactate are not for use in the treatment of lactic acidosis. to open: tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication prepare additive port. using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. the additive port may be protected by covering with an additive cap. mix container contents thoroughly

VOLULYTE 6% Australia - English - Department of Health (Therapeutic Goods Administration)

volulyte 6%

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l; sodium chloride, quantity: 6.02 g/l; potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of volulyte is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

Potassium Chloride 10 mmol in Sodium Chloride 0.9% (500 mL) New Zealand - English - Medsafe (Medicines Safety Authority)

potassium chloride 10 mmol in sodium chloride 0.9% (500 ml)

fresenius kabi new zealand limited - potassium chloride 1.5 mg/ml;  ; sodium chloride 9 mg/ml;  ;  ;   - solution for infusion - active: potassium chloride 1.5 mg/ml   sodium chloride 9 mg/ml       excipient: hydrochloric acid sodium hydroxide water for injection - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia.

Potassium Chloride 20 mmol in Sodium Chloride 0.9% (1000 mL) New Zealand - English - Medsafe (Medicines Safety Authority)

potassium chloride 20 mmol in sodium chloride 0.9% (1000 ml)

fresenius kabi new zealand limited - potassium chloride 1.5 mg/ml;  ; sodium chloride 9 mg/ml;  ;  ;   - solution for infusion - active: potassium chloride 1.5 mg/ml   sodium chloride 9 mg/ml       excipient: hydrochloric acid sodium hydroxide water for injection - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia.

Potassium Chloride 20 mmol in Sodium Chloride 0.9% (500 mL) New Zealand - English - Medsafe (Medicines Safety Authority)

potassium chloride 20 mmol in sodium chloride 0.9% (500 ml)

fresenius kabi new zealand limited - potassium chloride 3 mg/ml;  ; sodium chloride 9 mg/ml;  ;  ;   - solution for infusion - active: potassium chloride 3 mg/ml   sodium chloride 9 mg/ml       excipient: hydrochloric acid sodium hydroxide water for injection - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia.